LDC, the private equity arm of Lloyds Banking Group, has completed its exit of PAM Healthcare to Optima Healthcare. This transaction marks LDC's withdrawal from occupational health services. PAM Healthcare was acquired by Optima Healthcare, a private equity firm. The deal reflects LDC's strategic pivot away from healthcare towards other sectors, though specific terms weren't disclosed. LDC's exit from occupational health comes as private equity firms increasingly target consumer health products, particularly GLP-1 medications for chronic conditions.

Houlihan Lokey, a leading advisory firm, notes this trend underscores how preventative health products have become non-discretionary consumer purchases, driving deal activity in the sector. Consumer health deals now represent a significant portion of private equity activity, with firms prioritizing companies offering recurring revenue streams from essential wellness products. The acquisition suggests Optima Healthcare sees value in expanding its portfolio of non-discretionary health services.